Cargando...
Modulation of Sodium Iodide Symporter in Thyroid Cancer
Radioactive iodine (RAI) is a key therapeutic modality for thyroid cancer. Loss of RAI uptake in thyroid cancer inversely correlates with patient’s survival. In this review, we focus on the challenges encountered in delivering sufficient doses of I-131 to eradicate metastatic lesions without increas...
Gardado en:
| Publicado en: | Horm Cancer |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer US
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4458071/ https://ncbi.nlm.nih.gov/pubmed/25234361 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12672-014-0203-0 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|